You are here: Industry Insights > diabetes

News List

Medway NHS Foundation Trust to Transform Local Gestational Diabetes Screening by Offering World-First Home Oral Glucose Tolerance Testing (OGTT) Technology to All At-Risk Women Biotech Newswire
July 22, 2024
Digostics and Medway NHS Foundation Trust announced a partnership that will see the Trust become the latest maternity services provider to extend new remote OGTT to all expectant mothers who are at risk of developing gestational diabetes mellitus .
The Dynamic Diabetes and Metabolic Disorder Treatment Landscape Daivd Orchard Webb/PharmaSources
July 03, 2023
Diabetes is a chronic medical condition characterized by high levels of glucose in the blood.
Proposal to Have Empagliflozin as Option for Children with Type 2 Diabetes SHEM OIRERE
April 19, 2023
Manufacturers of Jardiance, which contains the drug empagliflozin, which is used in the treatment of diabetes in adults, seeking approval in the US to make a version of the medicine to meet increasing demand from this group of young diabetes patients.
Global Diabetes Market Outlook Dr. Preet Pal S.B.
November 22, 2021
Diabetes is a well-known metabolic disorder, and the number of people living with it continues to rise. Although it is a segment of opportunity for pharmaceutical manufacturers, understanding it is complex.
Chinese Developed New Drug Exploits the Field of Diabetes PharmaSources/Yi
November 01, 2021
Recently, the marketing application of chiglitazar sodium tablets, a new type 1 drug of Chipscreen (the relevant acceptance No. is CXHS1900032), has entered the administrative examination and approval stage, and it is expected that...
Good News in the Chinese Diabetes Field and Several Original Research Drugs Underway PharmaSources/Dopine
May 25, 2021
Glad tidings came recently in terms of supervision of two domestic diabetes drugs. Semaglutide, Novo Nordisk's blockbuster hypoglycemic drug, advanced to the administrative approval stage (acceptance number: JXSS2000005/6) on April 20.
Centralized procurement cuts insulin prices, benefits millions of diabetes patients www.gov.cn
April 22, 2023
China's diabetes patients now have access to high-quality and more affordable insulin products, as the country's drug bulk-buying program for insulin products has led to an average price cut of 48 percent.
Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment PharmaSources.com
March 25, 2022
Hitachi, Ltd. (TSE: 6501), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment.
Risk for Diabetes Increased for Pediatric Patients With COVID-19 drugs.com
January 21, 2022
Patients aged younger than 18 years with diagnosed COVID-19 have an increased...
'Artificial Pancreas' Can Help Kids With Type 1 Diabetes drugs.com
January 20, 2022
Having a child with type 1 diabetes can be a challenging health condition for parents to manage, but new research suggests an "artificial pancreas"...